- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04110262
Human Sodium Balance Study (MEASURE)
November 26, 2024 updated by: Cheryl Anderson, University of California, San Diego
Sodium Regulation in Individuals on Known Dietary Sodium Intake
The overall objective of this study is to examine how dietary sodium is used by the body.
In a racially diverse sample of adults, the investigators will examine the effects of high and low dietary sodium intake on the storage and excretion of sodium and determine whether sodium distribution affects blood pressure.
This has implications for how investigators interpret studies that use urine biomarkers of sodium.
Study findings about tissue sodium storage also have implications for managing hypertension and related conditions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92093
- University of California, San Diego
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 69 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- At least 18 years old;
- Diagnosed with high blood pressure or pre-hypertension (systolic blood pressure (SBP) > 120 mm Hg or diastolic blood pressure (DBP) > 80 mm Hg);
- Taking no more than two medications for high blood pressure;
- Currently has a primary care provider;
- Willing to eat all meals provided by the study for two 14-day feeding periods;
- Willing to complete study measurement procedures.
Exclusion Criteria:
- Diabetes;
- Smoker;
- Serious food allergies;
- Currently pregnant or planning to become pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High-low dietary sodium
High sodium diet (3400 mg/day) feeding period followed by low sodium diet (2300 mg/day) feeding period
|
Fourteen day feeding period of high dietary sodium (3400 mg/day)
Fourteen day feeding period of low dietary sodium (2300 mg/day)
|
|
Experimental: Low-high dietary sodium
Low sodium diet (2300 mg/day) feeding period followed by high sodium diet (3400 mg/day) feeding period
|
Fourteen day feeding period of high dietary sodium (3400 mg/day)
Fourteen day feeding period of low dietary sodium (2300 mg/day)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimated sodium concentration in skin and muscle
Time Frame: 60 days
|
The concentration of sodium in skin and muscle will be measured, and the difference in concentrations resulting from high versus low sodium intakes will be calculated.
Skin and muscle sodium stores will be non-invasively quantified using 23sodium-magnetic resonance imaging (23Na-MRI).
|
60 days
|
|
Estimated sodium concentration in bone
Time Frame: 60 days
|
The concentration of sodium in bone will be measured, and the difference in concentrations resulting from high versus low sodium intakes will be calculated.
Sodium storage in bone will be measured non-invasively using in vivo neutron activation analysis (IVNAA) technology to quantify the concentration of Na in the hand.
|
60 days
|
|
Concentration of sodium, potassium, and hormone regulators in excreted urine
Time Frame: 60 days
|
Urinary concentration of sodium, potassium, and hormones (renin, angiotensin, aldosterone, free cortisol, free cortisone, glucocorticoid, and mineralocorticoid) will be measured and variation over time will be calculated.
|
60 days
|
|
Blood pressure
Time Frame: 60 days
|
Blood pressure under high versus low dietary sodium conditions will be measured.
|
60 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Racial differences in concentrations of sodium in skin, muscle and bone
Time Frame: 60 days
|
Blacks/African Americans mean sodium concentrations versus the average of the means of each of the other racial/ethnic groups will be examined.
|
60 days
|
|
Racial differences in concentration of urinary potassium excretion
Time Frame: 60 days
|
The concentration of potassium excreted in urine will be compared between Blacks/African Americans versus the pooled sample of other racial/ethnic groups.
|
60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Cheryl A Anderson, PhD, University of California, San Diego
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 10, 2021
Primary Completion (Actual)
August 12, 2024
Study Completion (Actual)
August 12, 2024
Study Registration Dates
First Submitted
August 23, 2019
First Submitted That Met QC Criteria
September 27, 2019
First Posted (Actual)
October 1, 2019
Study Record Updates
Last Update Posted (Actual)
November 29, 2024
Last Update Submitted That Met QC Criteria
November 26, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HL140488
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on High dietary sodium intake
-
Texas State UniversityCompletedArterial Stiffness | Sodium IntakeUnited States
-
University of CopenhagenDairy Farmers of Canada; The Danish Dairy Research Foundation, Denmark; Dairy... and other collaboratorsCompleted
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
Vanderbilt UniversityWithdrawn
-
University of AarhusAarhus University Hospital; University of East Anglia; Kolding SygehusCompleted
-
Medical University of ViennaCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Dutch Kidney FoundationRecruitingChronic Kidney DiseasesNetherlands
-
Anglia Ruskin UniversityUniversity of ExeterCompletedMuscle Soreness | Protein-energy; ImbalanceUnited Kingdom
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompletedAutosomal Dominant Polycystic KidneyUnited States
-
Carmine ZoccaliCompletedEssential Hypertension.